Bactana, a Farmington, Conn.-based development stage animal health company, raised 1.3m in ts first funding.
The round included the conversion of outstanding convertible debt and interest. Investors included:
– Connecticut Innovations,
– Cornell University,
– Sustainable Income Capital Management, and
– other funds and private investors.
The company will use the funds to expand its laboratory at in its new facilities located at the UCONN Health Cell & Genome Science Center, perform additional trials using its FPS-4™ product platform, hire technical experts, and develop commercial manufacturing capabilities in preparation for its initial product launch.
Bactana Animal Health is developing sustainable products that enhance the microbiome of companion animals and improve efficiency of livestock farming while reducing the use of antibiotics and hormones in the world’s food supply. Its product platform is initially being developed for companion animals and food animals, where multiple trials have demonstrated increases in yield efficiency, weight gain, and improved gut health through enhancement to an animal’s microbiome.